ESTABLISHING THE PROCEDURE FOR DETERMINING rs1800629 VARIANT AT TNF- GENE PROMOTER REGION BY PCR-RFLP

Hữu Ngọc Tuấn Nguyễn, Hưng Thịnh Nguyễn, Thị Hồng Thắm Hồ

Main Article Content

Abstract

Introduction: A single nucleotide polymorphism (SNP) at promoter region of TNF-α gene, TNF-α-308G/A (rs1800629), which directly affects binding affinity of transcription factors to promoter region, leads to alter TNF-α gene expression and increase TNF-α level. In addition to the standard technique for SNPs detection, Sanger sequencing, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method is developed to determine rs1800629 with basic laboratory equipments, without requiring expensive chemicals and, additionally, provides highly reliable results. Determining rs1800629 at affordable cost is a favorable premise for researching on the effects of rs1800629 on many important pathogenetic and physiological characteristics. Objective: Establishing a molecular procedure to identify the TNF-α-308G/A (rs1800629) variant by Sanger sequencing and PCR-RFLP method. Method: Constructing Sanger sequencing procedure with self-designed primer pairs to determine a 400-500 bp DNA amplicon containing rs1800629. Cloning the control recombinant DNA plasmids containing respectively G allele and A allele of rs1800629 by using TA cloning method. Optimizing the conditions of PCR-RFLP protocol with NcoI restriction enzyme and applying rs1800629 detection procedure on 5 known genotype DNA samples of volunteers. Result: (1) Successfully constructed a Sanger sequencing process to detect rs1800629 variant using self-designed primer pairs; (2) created 2 DNA plasmids containing the G allele (wild-type) and A allele (variant) of the rs1800629 as genotype control samples, and (3) optimized the PCR-RFLP procedure to determine the rs1800629 variant including cleavage of PCR product with NcoI enzyme, and electrophoresis. All 5 DNA samples of volunteers with genotypes GG (3 samples), GA (1 sample) and AA (1 sample) were correctly diagnosed by PCR-RFLP method. Conclusion: The kit including Sanger sequencing, PCR-RFLP method and DNA plasmid controls was completed to determine TNF-α-308G/A (rs1800629) variant at promoter region of TNF-α gene.

Article Details

References

1. Abraham, L.J. and K.M. Kroeger, Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol, 1999. 66(4): p. 562-6.
2. Xia, Z., et al., Association Between TNF-alpha-308, +489, -238 Polymorphism, and COPD Susceptibility: An Updated Meta-Analysis and Trial Sequential Analysis. Front Genet, 2021. 12: p. 772032.
3. Sudershan, A., et al., Enlightening the association between TNF-alpha -308 G > A and migraine: a meta-analysis with meta-regression and trial sequential analysis. BMC Neurol, 2023. 23(1): p. 159.
4. Wang, B. and Y.L. He, Association of the TNF-alpha gene promoter polymorphisms at nucleotide -238 and -308 with acne susceptibility: a meta-analysis. Clin Exp Dermatol, 2019. 44(2): p. 176-183.
5. Lee, Y.H., et al., Association between TNF-alpha promoter -308 A/G polymorphism and Alzheimer's disease: a meta-analysis. Neurol Sci, 2015. 36(6): p. 825-32.
6. Corrêa, G.T., et al., Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma. Oral Oncol, 2011. 47(9): p. 888-94.